Page 22 - சன்னிபிரூக் ஆரோக்கியம் அறிவியல் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Amid third wave, U of Ts Homer Tien takes over provinces COVID-19 vaccine task force: CBC
pressreleasepoint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressreleasepoint.com Daily Mail and Mail on Sunday newspapers.
Sunnybrook s field hospital poised to handle overflow of COVID cases
torontosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from torontosun.com Daily Mail and Mail on Sunday newspapers.
A week after receiving the AstraZeneca COVID-19 vaccine, a 37-year-old woman in Norway went to the emergency department with fever and persistent headaches. A CAT scan of her head showed a blood clot in blood vessels involved in draining the brain, but her levels of platelets, involved in clotting, were low. She was treated with platelet infusions and a blood thinner, but had a bleed in her brain the next day. She underwent surgery to relieve the pressure on her brain but died two days later.
This is the side effect, known as cerebral venous sinus thrombosis, that has caused a week of worries around the COVID-19 vaccine developed by AstraZeneca. On Tuesday, the U.S. government said that it had seen the same effect six times among the 6.8 million people given a dose of a similar vaccine, from Johnson & Johnson, and that it recommended a pause on use of that vaccine out of an abundance of caution, while researchers investigated.
Health care calamity looms as COVID-19 cases surge across Canada
Health experts and even government officials now admit that the COVID-19 pandemic in Canada is at its most dangerous stage to date, with the pandemic’s third wave threatening to be the most lethal yet.
A nurse holds a phone while a patient affected with COVID-19 speaks with his family from the intensive care unit. (Image Credit: AP/Daniel Cole)
As a direct result of the criminal policies of all levels of government, which have prioritized corporate profits over human lives, COVID-19 has already killed more than 23,400 Canadians and infected 1.08 million.
OICR’s Drug Discovery Team is made up of 26 drug discovery scientists housed in state-of-art facilities with a mission to help Ontario’s researchers efficiently translate cancer related discoveries into novel oncology therapies. This team has “identified five of the most promising early stage oncology drug development projects in the province,” said Dr. Tom Hudson, the OICR’s president and scientific director. “OICR is pleased to support these Ontario-based research projects and we look forward to collaborating with our partners to help move them to the next stage of development,” he added.
The selected projects address a range of cancers, including hematological malignancies, triple negative breast cancer and colon cancer. They come from major institutions across Ontario and were selected from a province-wide call for proposals to identify promising oncology research that would benefit from OICR’s expertise in drug discovery.
vimarsana © 2020. All Rights Reserved.